SRPT
Sarepta Therapeutics, Inc. · Healthcare
Director Michael Andrew Chambers bought $2.6M of Sarepta Therapeutics, Inc.
Bought$2,559,272
$108.05Price
23,686Shares
+11%Stake
What SRPT did for a copier
- $1,000 copied at Mon, Aug 14 open, $108.02
- $1,105
- S&P 500, same days
- −3.9%
Measured over 30 trading days, to the Sep 26 close.
Michael Andrew Chambers's record
4 other buys with 3 months of prices since 2022: on average −7.6% against the S&P 500, and 2 of 4 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Aug 11. Filed Mon, Aug 14, 8:00 AM ET, before the open. Returns use the Aug 14 open and the Sep 26 close. Not investment advice.